课题基金 / 基金详情

IGF::OT::IGF A PHASE I DOSE ESCALATION STUDY OF TOPICAL BEXAROTENE IN WOMEN AT HIGH RISK FOR BREAST CANCER

IGF::OT::IGF A PHASE I DOSE ESCALATION STUDY OF TOPICAL BEXAROTENE IN WOMEN AT HIGH RISK FOR BREAST CANCER
IGF::OT::IGF 一期局部贝沙罗汀在乳腺癌高危女性中的剂量递增研究
批准号：
9575775
负责人：
POWEL BROWN
金额：
$38.2万
依托单位：
UNIVERSITY OF TX MD ANDERSON CAN CTR
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
项目状态：
已结题
起止时间：
2017-09-01 至 2017-09-23
来源：
https://reporter.nih.gov/project-details/9575775
关键词：
BexaroteneBreastClinical TrialsDoseEvaluationGelHigh Risk WomanInterventionMammary Gland ParenchymaMaximum Tolerated DosePhaseSafetyTestingToxic effectWomanmalignant breast neoplasm

项目摘要

项目成果

POWEL BROWN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The proposed clinical trial will evaluate safety and toxicity of topical bexarotene 1% gel to the breast in healthy women at high risk for breast cancer and bexarotene concentration in the breast tissue.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKERS; TASK ORDER: PREVENTION OF COLORECTAL CANCER WITH IPSC-
TASK ORDER: PRECLINICAL TESTING OF CD73 INHIBITORS FOR PANCREATIC CANCER IMMUNOPREVENTION
TASK ORDER: PRECLINICAL TESTING OF CD73 INHIBITORS FOR PANCREATIC CANCER IMMUNOPREVENTION
OTHER FUNCTIONS - CANCER PREVENTION AGENT DEVELOPMENT PROGRAM: EARLY PHASE CLINICAL RESEARCH
海外基金